SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-22-000057
Filing Date
2022-07-13
Accepted
2022-07-13 08:45:41
Documents
15
Period of Report
2022-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20220713.htm   iXBRL 8-K 49649
2 EX-10.1 goss-202207x13xexx101.htm EX-10.1 307282
3 EX-99.1 goss-20220713xexx991.htm EX-99.1 10485
7 GRAPHIC gossamerbio-logoxrega.jpg GRAPHIC 150783
  Complete submission text file 0001728117-22-000057.txt   770593

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20220713.xsd EX-101.SCH 1917
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20220713_lab.xml EX-101.LAB 24927
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20220713_pre.xml EX-101.PRE 13145
9 EXTRACTED XBRL INSTANCE DOCUMENT goss-20220713_htm.xml XML 10823
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 221080253
SIC: 2834 Pharmaceutical Preparations